JP2020534367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534367A5 JP2020534367A5 JP2020537858A JP2020537858A JP2020534367A5 JP 2020534367 A5 JP2020534367 A5 JP 2020534367A5 JP 2020537858 A JP2020537858 A JP 2020537858A JP 2020537858 A JP2020537858 A JP 2020537858A JP 2020534367 A5 JP2020534367 A5 JP 2020534367A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- subject
- growth factor
- fibroblast growth
- fat accumulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762561140P | 2017-09-20 | 2017-09-20 | |
| US62/561,140 | 2017-09-20 | ||
| PCT/EP2018/075471 WO2019057820A1 (en) | 2017-09-20 | 2018-09-20 | ABNORMAL VISCERAL GREASE DEPOSITION TREATMENT USING SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020534367A JP2020534367A (ja) | 2020-11-26 |
| JP2020534367A5 true JP2020534367A5 (enExample) | 2021-10-28 |
| JP7335247B2 JP7335247B2 (ja) | 2023-08-29 |
Family
ID=63878625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020537858A Active JP7335247B2 (ja) | 2017-09-20 | 2018-09-20 | 可溶性線維芽細胞増殖因子受容体３（ｓＦＧＦＲ３）ポリペプチドを使用した異常内臓脂肪蓄積の処置 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200297799A1 (enExample) |
| EP (1) | EP3684394A1 (enExample) |
| JP (1) | JP7335247B2 (enExample) |
| KR (1) | KR20200103621A (enExample) |
| CN (1) | CN111836634A (enExample) |
| AU (1) | AU2018335837A1 (enExample) |
| BR (1) | BR112020005459A2 (enExample) |
| CA (1) | CA3076396A1 (enExample) |
| IL (1) | IL273203A (enExample) |
| MX (1) | MX2020003114A (enExample) |
| PH (1) | PH12020550461A1 (enExample) |
| WO (1) | WO2019057820A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150344855A1 (en) | 2013-01-16 | 2015-12-03 | INSERM (Institut National de la Santé et de la Recherche Médicale | A Soluble Fibroblast Growth Factor Receptor 3 (FGR3) Polypeptide For Use In The Prevention Or Treatment Of Skeletal Growth Retardation Disorders |
| KR102432192B1 (ko) | 2016-07-07 | 2022-08-12 | 화이자 인코포레이티드 | 가용성 섬유아세포 성장 인자 수용체 3(sfgfr3) 폴리펩티드 및 이의 용도 |
| NL2020176B1 (en) * | 2017-12-22 | 2019-07-02 | Van Der Hoeven Horticultural Projects B V | Greenhouse |
| CN110272900B (zh) * | 2019-04-19 | 2024-03-26 | 中国人民解放军陆军军医大学 | 用于制备骨骼发育异常猪模型的sgRNA及其应用 |
| WO2022106976A1 (en) | 2020-11-18 | 2022-05-27 | Pfizer Inc. | Stable pharmaceutical formulations of soluble fgfr3 decoys |
| JP2022184798A (ja) | 2021-06-01 | 2022-12-13 | ファイザー・インク | ｓＦＧＦＲ３ポリペプチドを生産するための細胞培養方法 |
| WO2024147597A1 (ko) * | 2023-01-03 | 2024-07-11 | 서울대학교산학협력단 | Fgfr3 발현 또는 활성 억제제의 퇴행성 신경질환 치료 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040109850A1 (en) * | 2000-12-18 | 2004-06-10 | Neelam Jaiswal | Treatment of bone disorders by modulation of fgfr3 |
| US20150344855A1 (en) * | 2013-01-16 | 2015-12-03 | INSERM (Institut National de la Santé et de la Recherche Médicale | A Soluble Fibroblast Growth Factor Receptor 3 (FGR3) Polypeptide For Use In The Prevention Or Treatment Of Skeletal Growth Retardation Disorders |
| RS60593B1 (sr) * | 2014-01-24 | 2020-08-31 | Ngm Biopharmaceuticals Inc | Antitela koja vezuju domen 2 beta-kloto i postupci za njihovu upotrebu |
| CA2972865A1 (en) * | 2015-01-07 | 2016-07-14 | Therachon Sas | Soluble fgfr3 decoys for treating skeletal growth disorders |
| KR102432192B1 (ko) * | 2016-07-07 | 2022-08-12 | 화이자 인코포레이티드 | 가용성 섬유아세포 성장 인자 수용체 3(sfgfr3) 폴리펩티드 및 이의 용도 |
-
2018
- 2018-09-20 EP EP18788669.2A patent/EP3684394A1/en not_active Withdrawn
- 2018-09-20 KR KR1020207009844A patent/KR20200103621A/ko not_active Ceased
- 2018-09-20 JP JP2020537858A patent/JP7335247B2/ja active Active
- 2018-09-20 WO PCT/EP2018/075471 patent/WO2019057820A1/en not_active Ceased
- 2018-09-20 AU AU2018335837A patent/AU2018335837A1/en not_active Abandoned
- 2018-09-20 CN CN201880061038.6A patent/CN111836634A/zh active Pending
- 2018-09-20 CA CA3076396A patent/CA3076396A1/en active Pending
- 2018-09-20 US US16/649,208 patent/US20200297799A1/en not_active Abandoned
- 2018-09-20 BR BR112020005459-3A patent/BR112020005459A2/pt not_active IP Right Cessation
- 2018-09-20 MX MX2020003114A patent/MX2020003114A/es unknown
-
2020
- 2020-03-10 IL IL273203A patent/IL273203A/en unknown
- 2020-04-20 PH PH12020550461A patent/PH12020550461A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6499333B2 (ja) | オキシントモジュリン誘導体を含む高脂血症の治療のための組成物 | |
| CN112292144B (zh) | 激活素受体iib型变体及其使用方法 | |
| JP5274253B2 (ja) | 組織保護ペプチド及びその使用 | |
| AU2007215466B2 (en) | Long-acting polypeptides and methods of producing and administering same | |
| JP2021138740A (ja) | Ｇｉｐアゴニスト化合物及び方法 | |
| WO2011020319A1 (zh) | 调节血糖血脂的融合蛋白及其制备方法和应用 | |
| JPS63501567A (ja) | 生長因子 | |
| US20180280480A1 (en) | Compositions and peptides having dual glp-1r and glp-2r agonist activity | |
| WO2007094985A2 (en) | Long-acting polypeptides and methods of producing and administering same | |
| KR20130018965A (ko) | 목적 펩타이드의 혈장내 반감기 연장 작용을 가진 펩타이드 | |
| JP2003534384A (ja) | 神経保護性ペプチド | |
| JP2008500373A5 (enExample) | ||
| KR20210040818A (ko) | 글루카곤, 및 glp-1 수용체 및 gip 수용체 이중 작용제를 포함하는 조성물 및 이의 치료학적 용도 | |
| JP2019527053A (ja) | 可溶性線維芽細胞成長因子受容体３（ｓＦＧＦＲ３）ポリペプチドおよびその使用 | |
| JP2002538081A (ja) | Ｇｌｐ−１の類似体 | |
| JP2019527053A5 (enExample) | ||
| TWI921406B (zh) | 特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途 | |
| JPWO2014098249A1 (ja) | 組織修復活性組成物及びその利用 | |
| CN109414474B (zh) | 肝脏、胆道和胰腺障碍的治疗 | |
| JPWO2014141847A1 (ja) | 骨系統疾患治療薬及びその用途 | |
| EA019498B1 (ru) | Аналоги нейропептида y, содержащие по меньшей мере одну замену на синтетическую аминокислоту | |
| JP2002345468A5 (enExample) | ||
| JPH11506337A (ja) | 骨刺激因子 | |
| JPH05504069A (ja) | タイプ１ インターフェロン由来の新規変異体、それらの製造方法及びそれらの適用 | |
| TW202604565A (zh) | 用於預防或治療心血管疾病之三重ｇｌｐ－１／ｇｉｐ／升糖素受體促效劑及包含該促效劑之醫藥組成物 |